These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High dietary carbohydrates decrease gallbladder volume and enhance cholesterol crystal formation. Mathur A; Megan M; Al-Azzawi HH; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA Surgery; 2007 May; 141(5):654-9. PubMed ID: 17462466 [TBL] [Abstract][Full Text] [Related]
6. Leptin-resistant obese mice do not form biliary crystals on a high cholesterol diet. Graewin SJ; Lee KH; Tran KQ; Goldblatt MI; Svatek CL; Nakeeb A; Pitt HA J Surg Res; 2004 Dec; 122(2):145-9. PubMed ID: 15555610 [TBL] [Abstract][Full Text] [Related]
7. Leptin regulates gallbladder genes related to gallstone pathogenesis in leptin-deficient mice. Graewin SJ; Kiely JM; Lu D; Svatek CL; Al-Azzawi HH; Swartz-Basile DA; Pitt HA J Am Coll Surg; 2008 Mar; 206(3):503-10. PubMed ID: 18308222 [TBL] [Abstract][Full Text] [Related]
8. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats. Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776 [TBL] [Abstract][Full Text] [Related]
9. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455 [TBL] [Abstract][Full Text] [Related]
10. Leptin increases small intestinal response to cholecystokinin in leptin-deficient obese mice. Kiely JM; Graewin SJ; Pitt HA; Swartz-Basile DA J Surg Res; 2005 Mar; 124(1):146-50. PubMed ID: 15734493 [TBL] [Abstract][Full Text] [Related]
11. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone. Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone reverses insulin resistance and impaired CCK-stimulated pancreatic secretion in eNOS(-/-) mice: therapy for exocrine pancreatic disorders? Reddy RC; Hao Y; Lee SH; Gangireddy SR; Owyang C; DiMagno MJ Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G112-20. PubMed ID: 17510194 [TBL] [Abstract][Full Text] [Related]
13. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth. Towns R; Kostyo JL; Colca JR Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559 [TBL] [Abstract][Full Text] [Related]
14. The dipeptidyl peptidase-4 inhibitor alogliptin in combination with pioglitazone improves glycemic control, lipid profiles, and increases pancreatic insulin content in ob/ob mice. Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H Eur J Pharmacol; 2009 Jan; 602(2-3):448-54. PubMed ID: 19038243 [TBL] [Abstract][Full Text] [Related]
15. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats. Zanchi A; Perregaux C; Maillard M; Cefai D; Nussberger J; Burnier M Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1228-34. PubMed ID: 16835400 [TBL] [Abstract][Full Text] [Related]
16. Gallbladder motility in agouti-yellow and leptin-resistant obese mice. Tran KQ; Swartz-Basile DA; Nakeeb A; Pitt HA J Surg Res; 2003 Jul; 113(1):56-61. PubMed ID: 12943811 [TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice. Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870 [TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y deficiency attenuates responses to fasting and high-fat diet in obesity-prone mice. Patel HR; Qi Y; Hawkins EJ; Hileman SM; Elmquist JK; Imai Y; Ahima RS Diabetes; 2006 Nov; 55(11):3091-8. PubMed ID: 17065347 [TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients. Miyazaki Y; DeFronzo RA Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]